Ranbaxy Innovation and Growth Focus

Sales Breakup Across Geographies Ranbaxy is focused on developing Branded Gx in Emerging Market; sales are well distributed across Developed and Emerging markets CY 2012 As a % of Region/Business ($ Mn) Total North America 1,011 44% India Incl. SL 409 18% Eastern Europe + CIS 250 11% Developed Markets Western Europe 178 8% APAC + ME 107 5% Africa 177 8% LATAM 41 2% API + Others 138 6% Total Sales 2,312 100% Emerging Markets Emerging markets contribute ~60% of total DF sales excluding FTFs RANBAXY Trusted medicines.Healthier lives 10

View entire presentation